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http://dx.doi.org/10.1016/j.jds.2013.1Abstract Background/purpose: 5-Aminolevulinic acid mediated photodynamic therapy (ALA-
PDT) has been used for the treatment of precancerous lesions and oral cancers. Compared with
traditional treatment such as surgery, ALA-PDT can selectively kill cancer cells and reduce side
effects. However, some cells might survive from PDT and may be directly attributable to the
limited penetration of light. Therefore, it is necessary to elucidate alterations in cellular
behavior and molecular mechanisms in cancer cells that have survived from PDT.
Materials and methods: Human tongue squamous carcinoma cells, SCC-4 cells, and mice
bearing C26 tumors were used as cancer models in vitro and in vivo. After irradiation with
the LD50 (50% lethal dose) light dose, the ability of cellular migration and metastasis related
gene expression were assayed.
Results: Cells were rounded up and migration ability was shown to have significantly decreased
under the influence of irradiation with the LD50 light dose. Gene expression related to metas-
tasis including matrix metalloproteinases (MMPs) and chloride intracellular channel 4 (CLIC4)
was also reduced. In addition, in the animal tumor model, mRNA expression of MMP9 and CLIC4
was also noticeably decreased.stitute of Biomedical Materials and Tissue Engineering, Taipei Medical University, 250 Wu Xing Street,
.tw (T. Tsai).
to this work.
iation for Dental Sciences of the Republic of China. Published by Elsevier Taiwan LLC. All rights reserved.
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Effects of PDT in surviving cancer cells 75Conclusion: Our results indicate that PDT could reduce the expression of invasion related
genes of surviving cancer cells in vitro as well as in vivo. These could be used as references
for clinical PDT of oral cancer in the future.
Copyright ª 2013, Association for Dental Sciences of the Republic of China. Published by Else-
vier Taiwan LLC. All rights reserved.Introduction
5-Aminolevulinic acidmediatedphotodynamic therapy (ALA-
PDT) has been used to treat oral precancerous lesions and
oral cancers including oral squamous cell carcinoma.1,2
Compared with traditional treatment such as surgery, ALA-
PDT is less invasive and can selectively kill cancer cells and
reduce resultant side effects such as scar formation.3 How-
ever, ALA-PDT may cause a sublethal effect on cancer cells
due to the limited penetration of light. These survival cells
may raise the risk of cellular metastasis.4 Therefore, it is
necessary to elucidate alterations in cellular behavior and
molecular mechanisms in cancer cells survived from PDT.
PDT is a potential therapy for cancer treatment, which
combines a nontoxic photosensitizer, oxygen and light, to
generate cytotoxic species.5 After light irradiation, the
photosensitizer activates from a ground state to a higher
energy excited state. The activated photosensitizer may
subsequently react with molecules in its direct environment
by an electron transfer process to form radicals, which can
further interact with oxygen to produce reactive oxygen
species, such as superoxide anion radical, hydrogen
peroxide, and hydroxyl radical (type I reaction). The triplet
photosensitizer may directly transfer energy to oxygen to
also generate highly reactive singlet oxygen (type II reac-
tion). Singlet oxygen is the major product of the photody-
namic effect. Because of its short half-life and high
activity, singlet oxygen can only diffuse and react with
surrounding cells within 10e55 nm.6 Besides, ALA itself is
not a photosensitizer. While entering into a cell, it can be
converted into the photosensitizer, Protoporphyrin IX
(PpIX), in mitochondria resulting in damage to the cell after
a 630-nm wavelength irradiation.7 Compared with normal
cells, cancer cells are more likely to uptake ALA and
accumulate PpIX.7e9 These cells utilize the photosensitizing
agent that is able to photochemically eradicate malignant
cells without hugely damaging circumjacent normal cells.
Previously, we have proven the satisfying efficacy of a
sol-gel formulation of ALA in patients with oral verrucous
hyperplasia lesions and extensive oral verrucous carcinoma.
After treatment of the topical sol-gel form of ALA and
irradiation with a 635-nm light-emitting diode (LED) light
source, the lesion showed complete regression.10,11 For the
very common human papilloma virus which causes warts
that can affect many different sites including the face,
hands, feet, and genitalia, it was also demonstrated to be
an effective and painless treatment.12 Nevertheless, the
penetration of light and the concentration of a photosen-
sitizer still restrict the effect to the topical tissue. There is
the risk that the deeper lesion converts to a more aggres-
sive tumor via the ALA-PDT induced sublethal effect. The
relationship among the epidermal growth factor receptor(EGFR) and cell proliferation, angiogenesis, and metastasis
has been proven.13,14 The influence of ALA-PDT on the
ability of invasion and EGFR expression patterns in surviving
lung adenocarcinomas, melanoma, breast carcinoma, and
head and neck cancer cell lines have been reported.15,16
However, the cellular behavior and the molecular mecha-
nism of metastasis related gene expression such as EGFR
and matrix metalloproteinases (MMPs)17,18 are not clear. It
has been shown that reduced MMP9 and the change of
invasive ability induced by PDT are related to down-
regulation of chloride intracellular channel 4 (CLIC4).19,20
In the current study, we evaluated the migration ability
and metastasis involved genes such as EGFR, CLIC4, MMP2,
and MMP9 in surviving cancer cells, which provide evidence
that the alternation of cellular behavior resulted in
decreased cellular metastasis in oral cancer cells survived
from ALA-PDT. For application and to verify whether the
cellular behavior of SCC4 cells is ALA-PDT or is oral cancer
cell line specific, another type of photosensitizer, Chlorin
e6 (Ce6), and C26 tumor-bearing mice were also used in this
study. Ce6 is a type of photosensitizer compared with the
first generation of photosensitizers, such as hematopor-
phyrin, which is more potent in tumor cytotoxicity, has
stronger absorption at longer wavelengths, and has lower
side effects in skin.21 The purpose of this study is to verify
the efficacy and metastasis related gene expression in PDT
surviving cancer cells and the animal tumor model.Materials and methods
Cell culture and photodynamic treatment
The human tongue squamous cell carcinoma, SCC-4, was
cultured in DMEM/F12 (high-glucose Dulbecco’s modified
Eagle medium/nutrient mixture F-12; GIBCO, Grand Island,
NY) supplemented with 10% fetal bovine serum (FBS) and
400 ng/mL hydrocortisone (Sigma-Aldrich, St Louis, MO).
The murine colorectal cancer cell line, Colon-26 (C26), was
grown in RPMI-1640 medium, supplemented with 10% FBS.
The cultures were incubated at 37 C in an atmosphere
consisting of 5% CO2 and 95% air.
For ALA-PDT, SCC-4 cells were cultured in dishes or
plates and incubated with 1 mM ALA for 3 hours. Then cells
were exposed to various doses of light. The light source
consisted of high power LED array with the wavelength
centered at 635  5 nm.22 The fluence rate of an LED light
source is 60 mW/cm2.
For Ce6-PDT, after incubating C26 cells with 0.5 mg/mL
Ce6 for 2 hours, cells were washed with phosphate buffered
saline twice. Then, cells were irradiated by various doses of
light with a diode laser (662 nm, 105 mW/cm2).
Figure 1 The survival rate of SCC-4 cells after ALA-PDT with
various doses of light. Cells were incubated with 1 mM ALA and
then exposed to light irradiation at different light fluence. Cell
viability was assessed by MTT assay 24 hours after light irra-
diation. Data are mean  standard error of the mean obtained
from three independent experiments. ALA-PDT Z 5-
Aminolevulinic acid mediated photodynamic therapy;
MTT Z 3(4,5-dimethyl-thiazoyl-2-yl)-2,5-diphenyltetrazolium
bromide; SCC Z squamous carcinoma cells.
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cells were collected for further analysis.
Experimental animals
Male BALB/cByJ mice (in the weight range of 17e20 g; 6e8
weeks of age) were purchased from the National Laboratory
Animal Center (Taipei, Taiwan) and kept under controlled
lighting (14 hours light/10 hours dark) at a constant tem-
perature (23  2C), with water and NIH 31 laboratory
mouse food supplied ad libitum.
C26 cells were implanted in the right back of mice by
subcutaneous injection (2 105 cells permouse in 50 mL of no
phenol red RPMI-1640 medium). Mice were treated with Ce6
by intravenous injection through the tail vein when the
tumor had grown to 300 mm3 in volume. The concentration
of Ce6was 2.25mg/kg. Ce6was dilutedwith 0.9% NaCl. After
administering the chemical and being kept in the dark for 6
hours, the mice were irradiated with a laser light (wave-
length 662 nm, irradiance intensity 95 mW/cm2) and the
energy density was 100 J/cm2. After a period of 24 hours, the
mice were sacrificed and tumors were collected. The tumor
size was measured with an electronic balance and followed
the determined gene expression in the tumors.
3(4,5-Dimethyl-thiazoyl-2-yl)-2,5-
diphenyltetrazolium bromide assay
After being irradiated with 3 J/cm2, 6 J/cm2, 9 J/cm2, and
12 J/cm2 and then cultured in complete medium for 24
hours, cells were incubated with 0.2 mg/mL 3(4,5-
dimethyl-thiazoyl-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) solution to examine cell viability. MTT was diluted
with DMEM. After 2 hours, the formation of purple water
insoluble formazan product was dissolved by dimethyl
sulfoxide (DMSO) and then analyzed via a spectrophotom-
eter at an absorbance of 570 nm. Cells exposed to serum-
free, no phenol red medium but not light were used as
control. MTT activity (%) Z (mean absorbance of treated
cells/mean absorbance of control cells)  100%.
Migration assay
To verify the cellular ability of migration by using transwell,
cell suspensions (1  105 cells/well) were placed on the
upper layer of a cell permeable membrane and a solution
containing the complete medium was placed below the cell
permeable membrane. Following incubation for 24 hours,
the cells that migrated through the membrane were stained
with crystal violet and counted.
Gene expression
Total RNA was extracted from cells or tissue using Trizol
reagent (Invitrogen, Carlsbad, CA) according to the manu-
facturer’s protocol. cDNA was synthesized with random
primers and SuperScript II reverse transcriptase (Invi-
trogen). The mRNA expression level of each gene was
normalized to b-actin. The gene-specific primers were as
follows: MMP9, 50-GCCACCACCGCCAACTA-30 (forward) and
50-GCCACGAGGAACAAACTG-30 (reverse); MMP2, 50-GCAC-
CACTGAGGACTAGGA-30 (forward) and 50-CATCTTTCCGTCACTGCG-30 (reverse); EGFR, 50-GATAGACGCAGATAGTCGC-30
(forward) and 50-TTCTTCATCCATCAGGGCAC-30 (reverse);
CLIC4, 50-GCAGTGATGGTGAAAGCATAG-30 (forward) and 50-
TATAAATGGTGGGTGGGTCC-30 (reverse); b-actin 50-
TGGACTTCGAGCAAGAGATGG-30 (forward) and 50-ATCTCC
TTCTGCA-TCCTGTCG-30 (reverse).
Statistical analysis
Statistical analysis was conducted using a one-way analysis
of variance with Dunnett’s post hoc test using GraphPad
InStat software, version 3.00 for Windows (GraphPad Soft-
ware, San Diego, CA, USA).
Results
Sublethal dose of 5-aminolevulinic acid mediated
photodynamic therapy
To investigate the sublethal effect on SCC-4 cells, the
sublethal dose of ALA-PDT was verified first. After being
seeded in a 96-well plate overnight and further incubated
with 1 mM ALA for 3 hours, SCC-4 cells were irradiated by
3 J/cm2, 6 J/cm2, 9 J/cm2, and 12 J/cm2 with the LED array
(635  5 nm, 60 mW/cm2). Then, the MTT assay was used to
examine the survival rate of SCC-4 cells. As shown in Fig. 1,
the decrease in survival rate on SCC-4 cells after ALA-PDT
treatment related to the increasing of light dose (light
dose-dependent manner) and the LD50 (50% lethal dose)
was kept at around 6 J/cm2. We also observed the
morphology of these cells via a phase contrast microscope
(Fig. 2). With the increase of the light dose, the cell number
was diminished and cells were rounded up significantly
Figure 2 The morphology of SCC-4 cells after ALA-PDT. Cells were observed by using phase contrast microscopy. Under the light
dose of 6 J/cm2 and 9 J/cm2, cells were rounded up and the number of cells was significantly decreased. ALA-PDT Z 5-
Aminolevulinic acid mediated photodynamic therapy; SCC Z squamous carcinoma cells.
Effects of PDT in surviving cancer cells 77revealing the possibility that there is a change in the
cellular ability of migration.Migration ability
The ability of migration was assayed by using the transwell
migration assay. After treating SCC-4 cells with ALA-PDT
under the light dose of 6 J/cm2, the surviving cells were
placed on the upper layer of the transwell. Twenty-four
hours post-incubation, the migration rate was measured
via being stained with crystal violet and then counting the
migrated cells. The number migrated was normalized to
control SCC-4 cells. As shown in Fig. 3, as compared with
control cells, the relative cellular migration ability was
decreased to 4.4%.Figure 3 Cellular migration ability under the influence of
ALA-PDT. Representative images (top) of transwell migration
assay using complete medium (10% FBS) as chemoattractant
showed the migration ability of control and ALA-PDT (6 J/cm2)
treated SCC-4 cells. The migrated cells were stained with
crystal violet and counted. Results were obtained from three
independent experiments. The relative fold change in the
number of migrated cells is shown (below), with the results
from control cells given as 100%. ALA-PDT Z 5-Aminolevulinic
acid mediated photodynamic therapy; FBS Z fetal bovine
serum; SCC Z squamous carcinoma cells.Metastasis related gene expression
As ALA-PDT could reduce the migration ability and change
the shape of SCC-4 cells, we further verified the expression
level of metastasis related genes. After the excretion of
total RNA from LD50 (6 J/cm
2) and LD75 (9 J/cm
2) of ALA-Figure 4 The expression levels of MMP2, MMP9, and CLIC4
were reduced in cells treated with PDT. mRNA expression of
MMP2, MMP9, and CLIC4 in SCC-4 cells 24 hours post-ALA-PDT
under different light dose was assayed. (A) Reverse transcrip-
tion polymerase chain reaction (RT-PCR) results; (B) densito-
metric analysis. Data represent three independent
experiments, mean  standard deviation. ALA-PDT Z 5-
Aminolevulinic acid mediated photodynamic therapy;
CLIC4 Z chloride intracellular channel 4; MMP Z matrix met-
alloproteinase; SCC Z squamous carcinoma cells.
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MMP9, and CLIC4 were used for polymerase chain reaction
(PCR). The mRNA expression level was calculated and then
normalized to b-actin for lessening the initial variation in
sample concentrations (Fig. 4). Cells only exposed to ALA
without light were used as the control (ALA only). The
mRNA expression level of MMP2, MMP9, and CLIC4 was
shown in a light dose-dependent manner that decreased
depending on the increasing light dose. These results
demonstrated that cancer cells survived from ALA-PDT
exhibit reduced migration and were also related to down-
regulation of MMP2, MMP9, and CLIC4. However, there was
no significant difference between the control and ALA-PDT
treated surviving cells.Ce6 mediated photodynamic therapy
To investigate whether the change of metastasis related
gene expression is ALA-PDT specific and for clinical appli-
cation, Ce6 was used as a photosensitizer for photodynamic
treatment. After being incubated with Ce6 for 2 hours, C26
cells were irradiated by 0.25 J/cm2, 0.5 J/cm2, 0.75 J/cm2,
and 1 J/cm2. Twenty-four hours later, the total RNA of
survival cells was extracted for analysis of the expression
pattern for MMP9 and CLIC4. Cells were exposed to Ce6 but
no irradiation was used as the control (ALA only). The
decrease of CLIC4 expression was also highly related to
increasing light doses and MMP9 (Fig. 5). These results are
consistent with ALA-PDT survived SCC-4 cells. Furthermore,
we used BALB/cByJ mice bearing C26 tumors as the animal
model for demonstrating metastasis associated geneFigure 5 The expression levels of MMP9 and CLIC4 were reduced
mL Ce6 and exposure to light irradiation at different light fluence
transcription polymerase chain reaction. (A,B) Densitometric anal
from three independent experiments. The results represent the mea
are given as 1.0. Ce6 Z chlorin e6; CLIC4 Z chloride in
PDT Z photodynamic therapy.expression in vivo. Mice were treated with Ce6 at a dose of
2.25 mg/kg Ce6 by intravenous injection through the tail
vein when the tumor was grown to 300 mm3 in volume. Mice
injected with the same volume of 0.9% NaCl was used in the
control group. Six hours later, mice were irradiated with
laser light (wavelength 662 nm, irradiance intensity 95 mW/
cm2) and the energy density was set at 100 J/cm2. Twenty-
four hours post-irradiation, the mice were sacrificed and
the tumors were collected for determining the tumor size
and gene expression level. As shown in Fig. 6A, as compared
with the control mice, the tumor size of the Ce6-PDT
treated mice decreased by approximately 15%. CLIC4 and
MMP9 mRNA expression was significantly reduced (P s 0.01;
Fig. 6B). These results indicate that PDT could reduce the
expression of invasion related genes of surviving cancer
cells in vitro as well as in vivo.
Discussion
Under the influence of PDT, cellular migration and attach-
ment were suppressed in many cell lines.23,24 It has also
been proven that PDT results in a decrease in cellular in-
vasion in lung adenocarcinomas, melanoma, breast carci-
noma, and head and neck cancer cells lines.15,16 Besides,
the metastasis of highly related molecular cells, MMP2 and
MMP9, which show the ability to degrade the basement
membrane and extracellular matrix to promote the process
of migration and invasion,17,18 could be affected by
PDT.25e27 However, the mechanism with which PDT regu-
lates the alteration of MMP2 and MMP9 expression is still
unclear. Recently, we have shown that downregulation ofin C26 cells treated with Ce6-PDT: after incubation with 0.5 mg/
. MMP9 and CLIC4 expression levels were analyzed via reverse
ysis. Statistical analysis was performed according to the data
n  standard error of the mean for each group and control cells
tracellular channel 4; MMP Z matrix metalloproteinase;
Figure 6 Ce6-PDT in vivo. Ce6 was administrated through tail vein injection into BALB/cByJ mice bearing the C26 tumor. Six
hours later, 100 J/cm2 of light was applied. After 24 hours, mice were sacrificed and tumors were then collected. Mice injected
with the same volume of 0.9% NaCl were used as the control group. (A) Tumor size and (B) mRNA expression of MMP9 and CLIC4
(n Z 3). These results are represented as the mean  standard deviation for each group. **P < 0.01. Ce6 Z chlorin e6;
CLIC4 Z chloride intracellular channel 4; MMP Z matrix metalloproteinase; PDT Z photodynamic therapy.
Effects of PDT in surviving cancer cells 79CLIC4 is related to reduced MMP9 and suppressed inva-
siveness induced by PDT in human lung adenocarcinoma,
melanoma cells, etc.19 In addition, CLIC4 has the ability to
regulate the proliferation and differentiation as well as to
assist the angiogenesis in tumor cells.28,29 Tumorestroma
crosstalk signaling, which promoted the conversion of
fibroblast to a more aggressive stromal myofibroblast, and
the relationship with tumorgenesis of CLIC4 were also re-
ported.20,30,31 In this study, the suppressed migration and
CLIC4, MMP2, and MMP9 expression proven in ALA-PDT
caused sublethal SCC-4 cells. Furthermore, the reduction
of gene expression was shown in a light dose-dependent
manner. It suggests that the suppression of cellular migra-
tion may depend on the efficacy of ALA-PDT.
After ALA-PDT treatment, SCC-4 cells rounded up
noticeably (Fig. 2; 9 J/cm2). It seems similar to the disor-
ganization of the cytoskeleton in cells resistant to PDT.32
The rearrangement of the cytoskeleton was modulated by
the FAK (focal adhesion kinase)eSrc kinase complex and
associated with the alternation of cell motility and focal
contact.33 Inhibition of the phosphorylation of FAK, Src ki-
nase, and its downstream extracellular signal-regulated
kinase by sublethal PDT in head and neck cancer cell lines
has been reported.16 The rounded morphology induced by
PDT also seems involved in migration suppression in SCC-4
cells. The alternation of the cytoskeletal arrangement
and the molecular mechanism in ALA-PDT induced sublethal
SCC-4 cells needs more investigation.
In PDT-treated cells, downregulation of EGFR has been
notable in vitro and in vivo.15,34 Overexpression of EGFR is
common in many types of human tumors and is often
correlated with the enhancement of cellular proliferation
and metastasis.35,36 Compared with parental SCC-4 cells,
the surviving cells showed significantly suppressed cellularmigration (Fig. 3). Surprisingly, the expression of EGFR
mRNA was not decreased like CLIC4, MMP2, and MMP9
(Fig. 4). Both EGFR-dependent and EGFR-independent
mechanisms of promoting the growth and survival were
found in clinical specimens from head and neck squamous
cell carcinoma patients and oral squamous cell carcino-
genesis animal models.37,38 These may be associated with
the rendering of the EGFR inhibitor not applicable as a
single therapeutic agent39 and the uniformity of the EGFR
expression pattern in our results.
The results of Ce6-PDT showed that reduced CLIC4 and
MMP9 expression is not ALA-PDT specific and the possibility
of a suppressed migration of cancer cells survived from
Ce6-PDT in vivo. PDT seems to have the potential of
inhibiting the invasiveness and metastasis of cancer cells,
which means it could have great potential for the treat-
ment of oral precancerous lesions and oral cancers.
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